Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
Exceptional clinical leadership in the 21st century demands strong communication skills and the ability to listen to colleagues. Effective leadership necessitates a cultural shift within organisations, fostering openness and innovation.
Catch up on insightful discussions from the expert panel featuring…
Congratulations on the launch of "Every Dose Used-Reducing Wasted Medicines Playbook" co-authored by Deloitte & @YewMaker on behalf of the Sustainable Medicines Partnership. Download the report here.